Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
Conmed's BioBrace Implant Shows Promise but Awaits Crucial Trial Results Amid Financial Considerations
Why Conmed (CNMD) Is a Top Growth Stock for the Long-Term
Top 3 Health Care Stocks That May Dip This Month
CONMED (NYSE:CNMD) Seems To Use Debt Quite Sensibly
CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference
We Think That There Are Issues Underlying CONMED's (NYSE:CNMD) Earnings
Stifel Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $72
Results: CONMED Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates
A Quick Look at Today's Ratings for ConMed(CNMD.US), With a Forecast Between $72 to $97
A Quick Look at Today's Ratings for ConMed(CNMD.US), With a Forecast Between $74 to $97
ConMed | 10-Q: Q3 2024 Earnings Report
Conmed Analyst Ratings
Express News | Conmed Corporation : Wells Fargo Raises Target Price to $74 From $71
Conmed Corp (CNMD) Q3 2024 Earnings Call Highlights: Strong U.S. ...
CONMED Corporation (CNMD) Q3 2024 Earnings Call Transcript Summary
Earnings Flash (CNMD) CONMED CORPORATION Reports Q3 Revenue $316.7M
CONMED Reports Q3 Results
Conmed Longtime CEO Hartman to Retire, Operating Chief Beyer Named Replacement
ConMed | 8-K: CONMED Corporation Announces Third Quarter 2024 Financial Results